In summary, our data indicate that FAM46C was associated with prognosis of prostate cancer patients and its overexpression suppressed cell growth of prostate cancer through PTEN/AKT signaling pathway, which may serves as a mode that mediates prostate cancer cell response to chemotherapy. This evidence concerns the gene PTEN and prostate cancer.